These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

112 related items for PubMed ID: 6779102

  • 1. DOPA metabolism in neuroblastoma.
    Helson L, Johnson GA, Smith R.
    Med Pediatr Oncol; 1980; 8(4):317-22. PubMed ID: 6779102
    [Abstract] [Full Text] [Related]

  • 2. Evaluation of plasma 3,4-dihydroxyphenylacetic acid (DOPAC) and plasma 3,4-dihydroxyphenylalanine (DOPA) as tumor markers in children with neuroblastoma.
    Eldrup E, Clausen N, Scherling B, Schmiegelow K.
    Scand J Clin Lab Invest; 2001; 61(6):479-90. PubMed ID: 11681538
    [Abstract] [Full Text] [Related]

  • 3. Plasma dopa and catecholamines in the diagnosis and follow-up of children with neuroblastoma.
    Alvarado CS, Faraj BA, Kim TH, Camp VM, Bain RP, Ragab AH.
    Am J Pediatr Hematol Oncol; 1985; 7(3):221-7. PubMed ID: 3934994
    [Abstract] [Full Text] [Related]

  • 4. Combined measurements of plasma aromatic L-amino acid decarboxylase and DOPA as tumour markers in diagnosis and follow-up of neuroblastoma.
    Boomsma F, Ausema L, Hakvoort-Cammel FG, Oosterom R, Man in't Veld AJ, Krenning EP, Hahlen K, Schalekamp MA.
    Eur J Cancer Clin Oncol; 1989 Jul; 25(7):1045-52. PubMed ID: 2503383
    [Abstract] [Full Text] [Related]

  • 5. 3,4-dihydroxyphenylalanine (DOPA) metabolism in screening-detected and non-screening-detected neuroblastoma.
    Ikeda H, Suzuki N, Takahashi A, Kuroiwa M, Matsuyama S.
    Pediatr Hematol Oncol; 1996 Jul; 13(1):21-32. PubMed ID: 8718500
    [Abstract] [Full Text] [Related]

  • 6. Catecholamine metabolism in neuroblastoma.
    LaBrosse EH, Comoy E, Bohuon C, Zucker JM, Schweisguth O.
    J Natl Cancer Inst; 1976 Sep; 57(3):633-8. PubMed ID: 10450
    [Abstract] [Full Text] [Related]

  • 7. 3,4-dihydroxyphenylalanine (DOPA) decarboxylase deficiency and resultant high levels of plasma DOPA and dopamine in unfavorable neuroblastoma.
    Ikeda H, Matsuyama S, Suzuki N, Takahashi A, Kuroiwa M.
    Hypertens Res; 1995 Jun; 18 Suppl 1():S209-10. PubMed ID: 8529065
    [Abstract] [Full Text] [Related]

  • 8. Determination of urinary vanillactic acid and plasma dihydroxyphenylalanine as markers of non-secreting neuroblastoma by high-performance liquid chromatography with electrochemical detection.
    Jouve J, Bakri D, Herault J, Muh JP.
    J Chromatogr; 1991 Jul 05; 567(2):331-41. PubMed ID: 1939466
    [Abstract] [Full Text] [Related]

  • 9. Inhibition of catecholamine biosynthesis by carbidopa and metyrosine in neuroblastoma.
    Anton AH, Crumrine RS, Stern RC, Izant RJ.
    Pediatr Pharmacol (New York); 1983 Jul 05; 3(2):107-17. PubMed ID: 6425794
    [Abstract] [Full Text] [Related]

  • 10. Determination of 3,4-dihydroxyphenylalanine (DOPA) in plasma and cerebrospinal fluid by high performance liquid chromatography with electrochemical detection.
    Boomsma F, van der Hoorn FA, Man in 't Veld AJ, Schalekamp MA.
    Clin Chim Acta; 1988 Nov 05; 178(1):59-69. PubMed ID: 3147824
    [Abstract] [Full Text] [Related]

  • 11. Metabolism of L-3,4-dihydroxyphenylalanine-2,5,6-3H and 3,4-dihydroxyphenylethylamine-2-14C in a patient with neuroblastoma.
    Imashuku S, LaBrosse EH.
    J Clin Endocrinol Metab; 1971 Feb 05; 32(2):241-53. PubMed ID: 5539035
    [No Abstract] [Full Text] [Related]

  • 12. Elevation of cerebrospinal fluid catecholamine metabolites in patients with intracranial tumors of neuroectodermal origin.
    Bostrom B, Mirkin BL.
    J Clin Oncol; 1987 Jul 05; 5(7):1090-7. PubMed ID: 3598613
    [Abstract] [Full Text] [Related]

  • 13. 3,4-dihydroxyphenylalanine (dopa) metabolism and retinoic acid induced differentiation in human neuroblastoma.
    Ikeda H, Pastuszko A, Ikegaki N, Kennett RH, Wilson DF.
    Neurochem Res; 1994 Dec 05; 19(12):1487-94. PubMed ID: 7877718
    [Abstract] [Full Text] [Related]

  • 14. Plasma 3,4-dihydroxyphenylalanine (dopa) and catecholamines in neuroblastoma or pheochromocytoma.
    Goldstein DS, Stull R, Eisenhofer G, Sisson JC, Weder A, Averbuch SD, Keiser HR.
    Ann Intern Med; 1986 Dec 05; 105(6):887-8. PubMed ID: 3096183
    [No Abstract] [Full Text] [Related]

  • 15. Three years of experience with random urinary homovanillic and vanillylmandelic acid levels in the diagnosis of neuroblastoma.
    Tuchman M, Ramnaraine ML, Woods WG, Krivit W.
    Pediatrics; 1987 Feb 05; 79(2):203-5. PubMed ID: 3808793
    [Abstract] [Full Text] [Related]

  • 16. Metabolic fate of l-[14C] DOPA in cerebrospinal fluid and blood plasma of humans.
    Pletscher A, Bartholini G, Tissot R.
    Brain Res; 1967 Feb 05; 4(1):106-9. PubMed ID: 6029941
    [No Abstract] [Full Text] [Related]

  • 17. Radioenzymatic assay of DOPA (3,4-dihydroxyphenylalanine).
    Johnson GA, Gren JM, Kupiecki R.
    Clin Chem; 1978 Nov 05; 24(11):1927-30. PubMed ID: 709823
    [Abstract] [Full Text] [Related]

  • 18. Studies on tyrosine hydroxylase in neuroblastoma in relation to urinary levels of catecholamine metabolites.
    Imashuku S, Takada H, Sawada T, Nakamura T, LaBrosse EH.
    Cancer; 1975 Aug 05; 36(2):450-7. PubMed ID: 239788
    [Abstract] [Full Text] [Related]

  • 19. Neuroblastoma and bone metastases: clinical significance and prognostic value of Dickkopf 1 plasma levels.
    Granchi D, Corrias MV, Garaventa A, Baglìo SR, Cangemi G, Carlini B, Paolucci P, Giunti A, Baldini N.
    Bone; 2011 Jan 05; 48(1):152-9. PubMed ID: 20603237
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.